STI stirling products limited

massive volume, roadshow

  1. 222 Posts.
    The first 90 mins of trading is shaping up to be the start of STI's most volume traded day on record and technically looking like a good entry as its breaking from a nice rounded bottom / consolidation pattern.

    The 3rd most traded by volume on the ASX today.

    They successfully raised 1.4million in feb at .012 so cap raising is out of the way

    from their ann today

    " Stirling Pharma starts manufacturing in Q2
    Launch of Stirling Health sales to pharmacies commence April Q2
    Launch of Natures Firewall Internet sales network based in Canada to
    launch in Q2
    Launch of i-Naturals USA based network marketing health, beauty and
    anti-aging products to launch in Q4 or Q1, 2011
    Joint venturing of products and/or technologies - ongoing
    Licensing of products, in and out - ongoing
    Relationship establishment with governments and continued clinical trials in
    areas of unmet need such as TB and HIV throughout the Africa ongoing
    Development of pre-production inhalation platform devices - ongoing

    Underpinned by Tangible Assets
    $20M+ replacement value - near new, freehold pharmaceutical plant
    Freehold offices est. value $2.5 million

    Positioned for:
    significant sales revenues commencing early Q2
    realization of major blockbuster potential opportunities
    - ImmunoXel as a treatment adjunct for AIDS and TB
    - inhalation drug delivery platform
    - obesity drug candidate
    joint ventures with major pharmas
    continued aggressive growth"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.